Dr. Michael J. Morris Imaging with 18F-DCFPyL–PET/CT was found to be diagnostically effective, often guiding a change in treatment plan, in men with biochemically relapsed prostate cancer, according to the results of the phase III CONDOR study presented during the ASCO20 Virtual Scientific Program (Abstract 5501). “There is ample evidence that prostate-specific membrane…
The Thoracic Surgery Oncology Group (TSOG) is a joint initiative between the American Association for Thoracic Surgery and the Fiona & Stanley Druckenmiller Center for Lung Cancer…
Join us for a night of fun at MSK’s annual Comedy vs. Cancer event and help us outsmart blood cancer.
This survey study assesses the current state of decentralized trial technology adoption and highlights industry aspirations and directions for use to enable more patient-centric trials.
An internationally recognized surgeon-scientist, Dr. Drebin has been named 2024 President-Elect of the American Surgical Association.
MSK investigators presented new research on a range of important topics at the 2024 Annual Meeting of the American Association for Cancer Research.
PSA testing is an important part of screening for prostate cancer, when it’s used the right way. Learn the truth dispelling seven myths about the…
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her…
In a plenary presentation at the 2024 American Association for Cancer Research (AACR) Annual Meeting, Dr. Dana Pe’er highlighted three recent research collaborations between her…
New data presented today by Memorial Sloan Kettering Cancer Center (MSK) researchers show an experimental approach to treating pancreatic cancer with the messenger RNA (mRNA)-based…
Learn how MSK researchers are deploying mRNA vaccines against pancreatic cancer.
